Iron Chelation in Chemotherapy

This publication has 73 references indexed in Scilit:

• Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
  The Lancet, 2002
• Deferiprone protects against doxorubicin-induced myocyte cytotoxicity
  Free Radical Biology & Medicine, 2002
• The Effect of Apo‐Transferrin on Bacterial Adhesion to Biomaterials
  Artificial Organs, 2002
• HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning
  Blood, 2002
• Experimental Results on Chloroquine and AIDS-Related Opportunistic Infections
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Deferiprone
  Drugs, 1999
• Systemic Administration of the Iron Chelator Deferiprone Attenuates Subarachnoid Hemorrhage-induced Cerebral Vasospasm in the Rabbit
  Neurosurgery, 1997
• Plasma free iron and chemotherapy toxicity
  The Lancet, 1996
• Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect
  Kidney International, 1994
• Desferrioxamine
  Reviews in Medical Microbiology, 1993